Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis.

The basic helix-loop-helix transcription factor stem cell leukemia gene (Scl) is a master regulator for hematopoiesis essential for hematopoietic specification and proper differentiation of the erythroid and megakaryocyte lineages. However, the critical downstream targets of Scl remain undefined. Here, we identified a novel Scl target gene, transcription factor myocyte enhancer factor 2 C (Mef2C) from Scl(fl/fl) fetal liver progenitor cell lines. Analysis of Mef2C(-/-) embryos showed that Mef2C, in contrast to Scl, is not essential for specification into primitive or definitive hematopoietic lineages. However, adult VavCre(+)Mef2C(fl/fl) mice exhibited platelet defects similar to those observed in Scl-deficient mice. The platelet counts were reduced, whereas platelet size was increased and the platelet shape and granularity were altered. Furthermore, megakaryopoiesis was severely impaired in vitro. Chromatin immunoprecipitation microarray hybridization analysis revealed that Mef2C is directly regulated by Scl in megakaryocytic cells, but not in erythroid cells. In addition, an Scl-independent requirement for Mef2C in B-lymphoid homeostasis was observed in Mef2C-deficient mice, characterized as severe age-dependent reduction of specific B-cell progenitor populations reminiscent of premature aging. In summary, this work identifies Mef2C as an integral member of hematopoietic transcription factors with distinct upstream regulatory mechanisms and functional requirements in megakaryocyte and B-lymphoid lineages.

[1]  Michelle M. Sandau,et al.  Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation , 2008, Nature Immunology.

[2]  E. Olson,et al.  The MADS transcription factor Mef2c is a pivotal modulator of myeloid cell fate. , 2008, Blood.

[3]  E. Papoutsakis,et al.  Gene Ontology-driven transcriptional analysis of CD34+ cell-initiated megakaryocytic cultures identifies new transcriptional regulators of megakaryopoiesis. , 2008, Physiological genomics.

[4]  S. Orkin,et al.  The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation. , 2008, Cell stem cell.

[5]  H. Drexler,et al.  MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines , 2008, Leukemia.

[6]  John McAnally,et al.  MEF2C transcription factor controls chondrocyte hypertrophy and bone development. , 2007, Developmental cell.

[7]  S. Orkin,et al.  The journey of developing hematopoietic stem cells , 2006, Development.

[8]  Mark A. Hall,et al.  A critical role for the transcription factor Scl in platelet production during stress thrombopoiesis. , 2006, Blood.

[9]  T. Golub,et al.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9 , 2006, Nature.

[10]  M. Teitell,et al.  Transcriptional Activators, Repressors, and Epigenetic Modifiers Controlling Hematopoietic Stem Cell Development , 2006, Pediatric Research.

[11]  N. Copeland,et al.  Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis. , 2005, Blood.

[12]  Mark A. Hall,et al.  Functional but Abnormal Adult Erythropoiesis in the Absence of the Stem Cell Leukemia Gene , 2005, Molecular and Cellular Biology.

[13]  Hyeyoung Min,et al.  Effects of aging on early B‐ and T‐cell development , 2005, Immunological reviews.

[14]  B. Blomberg,et al.  B cells, E2A, and aging , 2005, Immunological reviews.

[15]  S. Orkin,et al.  Tie2Cre-mediated gene ablation defines the stem-cell leukemia gene (SCL/tal1)-dependent window during hematopoietic stem-cell development. , 2005, Blood.

[16]  T. Graf,et al.  Assessing the role of hematopoietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing , 2004, Development.

[17]  T. Hoang,et al.  SCL Assembles a Multifactorial Complex That Determines Glycophorin A Expression , 2004, Molecular and Cellular Biology.

[18]  Long-Sheng Chang,et al.  Identification of a TAL1 Target Gene Reveals a Positive Role for the LIM Domain-Binding Protein Ldb1 in Erythroid Gene Expression and Differentiation , 2003, Molecular and Cellular Biology.

[19]  E. Dodou,et al.  mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo , 2003, Mechanisms of Development.

[20]  Wei Xu,et al.  B cell precursors in senescent mice exhibit decreased recruitment into proliferative compartments and altered expression of Bcl-2 family members , 2003, Mechanisms of Ageing and Development.

[21]  S. Orkin,et al.  Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene , 2003, Nature.

[22]  Donald Metcalf,et al.  The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Orkin,et al.  Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo. , 2003, Blood.

[24]  D. Naiman,et al.  New genes involved in cancer identified by retroviral tagging , 2002, Nature Genetics.

[25]  H. Igarashi,et al.  Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. , 2002, Immunity.

[26]  E. Olson,et al.  The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development. , 2001, Development.

[27]  A. Cumano,et al.  Intraembryonic, but not yolk sac hematopoietic precursors, isolated before circulation, provide long-term multilineage reconstitution. , 2001, Immunity.

[28]  M. Kennedy,et al.  A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1. , 2000, Development.

[29]  L. Zon,et al.  Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding. , 1999, Development.

[30]  C. Drake,et al.  The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF. , 1999, Developmental biology.

[31]  S. Orkin,et al.  Intersections between blood cell development and leukemia genes. , 1999, Cancer research.

[32]  G. Lyons,et al.  Requirement of the MADS-box transcription factor MEF2C for vascular development. , 1998, Development.

[33]  W. Telford,et al.  Increased apoptosis of bone marrow pre-B cells in old mice associated with their low number. , 1998, International immunology.

[34]  T. Hawley,et al.  Overexpression of HOX11 leads to the immortalization of embryonic precursors with both primitive and definitive hematopoietic potential. , 1998, Blood.

[35]  G. Lyons,et al.  Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes. , 1998, Molecular immunology.

[36]  S. Orkin,et al.  Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. , 1998, Genes & development.

[37]  A. Elefanty,et al.  Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells. , 1997, Blood.

[38]  C. Bucana,et al.  Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. , 1997, Science.

[39]  E. Olson,et al.  Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  C. Begley,et al.  The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. , 1996, The EMBO journal.

[41]  B. Black,et al.  Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins , 1995, Cell.

[42]  S. Orkin,et al.  Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL , 1995, Nature.

[43]  A. Cumano,et al.  Emergence of multipotent hemopoietic cells in the yolk sac and paraaortic splanchnopleura in mouse embryos, beginning at 8.5 days postcoitus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Craig Montell,et al.  Complete transformation by adenovirus 2 requires both E1A proteins , 1984, Cell.

[45]  E. Papoutsakis,et al.  Title: Gene-Ontology driven transcriptional analysis of CD34 + -cell initiated megakaryocytic cultures identifies new transcriptional regulators of megakaryopoiesis Running title: Microarray analysis of Mk transcription factors , 2008 .

[46]  Alexander E. Kel,et al.  TRANSFAC®: transcriptional regulation, from patterns to profiles , 2003, Nucleic Acids Res..

[47]  R. Hardy,et al.  B cell development pathways. , 2001, Annual review of immunology.

[48]  N. Testa,et al.  Haemopoiesis : a practical approach , 1993 .

[49]  L. Zon,et al.  Hematopoiesis: An Evolving Paradigm for Stem Cell Biology , 2008, Cell.